{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:08:10Z","timestamp":1788520090913,"version":"build-2803163510"},"reference-count":92,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2020,1,5]],"date-time":"2020-01-05T00:00:00Z","timestamp":1578182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Botulinum neurotoxins (BoNT) possess an analgesic effect through several mechanisms including an inhibition of acetylcholine release from the neuromuscular junction as well as an inhibition of specific pain transmitters and mediators. Animal studies have shown that a peripheral injection of BoNTs impairs the release of major pain transmitters such as substance P, calcitonin gene related peptide (CGRP) and glutamate from peripheral nerve endings as well as peripheral and central neurons (dorsal root ganglia and spinal cord). These effects lead to pain relief via the reduction of peripheral and central sensitization both of which reflect important mechanisms of pain chronicity. This review provides updated information about the effect of botulinum toxin injection on local pain caused by cancer, painful muscle spasms from a remote cancer, and pain at the site of cancer surgery and radiation. The data from the literature suggests that the local injection of BoNTs improves muscle spasms caused by cancerous mass lesions and alleviates the post-operative neuropathic pain at the site of surgery and radiation. It also helps repair the parotid damage (fistula, sialocele) caused by facial surgery and radiation and improves post-parotidectomy gustatory hyperhidrosis. The limited literature that suggests adding botulinum toxins to cell culture slows\/halts the growth of certain cancer cells is also reviewed and discussed.<\/jats:p>","DOI":"10.3390\/toxins12010032","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T03:48:48Z","timestamp":1578282528000},"page":"32","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Botulinum Neurotoxins and Cancer\u2014A Review of the Literature"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2138-1108","authenticated-orcid":false,"given":"Shivam O.","family":"Mittal","sequence":"first","affiliation":[{"name":"Head, Section for Parkinson\u2019s Disease and Movement Disorders, Cleveland Clinic Abu Dhabi, Abu Dhabi 112412, UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahman","family":"Jabbari","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yale University School of Medicine, New Haven, CT 06519, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,1,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/mds.27072","article-title":"Botulinum toxin: State of the Art","volume":"32","author":"Jankovic","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Jabbari, B. (2018). A disease- oriented approach. Botulinum Toxin Treatment in Clinical Medicine, Springer.","DOI":"10.1007\/978-3-319-56038-0"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1526-4610.43.7s.3.x","article-title":"Evidence for antinociceptive activity of botulinum toxin type A in pain management","volume":"43","author":"Aoki","year":"2003","journal-title":"Headache"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1526-4610.2010.01678.x","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: Pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program","volume":"50","author":"Dodick","year":"2010","journal-title":"Headache"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.3390\/toxins7083127","article-title":"Botulinum Toxin for Neuropathic Pain: A Review of the Literature","volume":"7","author":"Oh","year":"2015","journal-title":"Toxins"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Park, J., and Park, H.J. (2017). Botulinum Toxin for the Treatment of Neuropathic Pain. Toxins, 9.","DOI":"10.3390\/toxins9090260"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.toxicon.2018.01.017","article-title":"Botulinum toxin treatment of pain syndromes\u2014An evidence based review","volume":"147","author":"Safarpour","year":"2018","journal-title":"Toxicon"},{"key":"ref_8","first-page":"40","article-title":"Botulinum Toxin for Side-Effect Management and Prevention of Surgical Complications in Patients Treated for Head and Neck Cancers and Esophageal Cancer","volume":"10","author":"Shaw","year":"2019","journal-title":"J. Adv. Pract. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.joms.2016.01.038","article-title":"Use of Botox (OnabotulinumtoxinA) for the Treatment of Parotid Sialocele and Fistula After Extirpation of Buccal Squamous Cell Carcinoma with Immediate Reconstruction Using Microvascular Free Flap: A Report of 3 Cases","volume":"74","author":"Melville","year":"2016","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/cam4.504","article-title":"Efficacy and safety of botulinum toxin type A for treatment of Frey\u2019s syndrome: Evidence from 22 published articles","volume":"4","author":"Xie","year":"2015","journal-title":"Cancer Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tox.2015.07.003","article-title":"Botulinum neurotoxin type A: Actions beyond SNAP-25?","volume":"335","author":"Matak","year":"2015","journal-title":"Toxicology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1001\/archotol.128.8.956","article-title":"Head and neck muscle spasm after radiotherapy: Management with botulinum toxin A injection","volume":"128","author":"Finnegan","year":"2002","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/01.sla.0000141156.56314.1f","article-title":"Botulinum toxin infiltration for pain control after mastectomy and expander reconstruction","volume":"240","author":"Layeeque","year":"2004","journal-title":"Ann. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hed.10340","article-title":"Botulinum toxin type A for the treatment of chronic neck pain after neck dissection","volume":"26","author":"Vasan","year":"2004","journal-title":"Head Neck"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/01.mlg.0000217797.05523.75","article-title":"Botulinum toxin A for neuropathic pain after neck dissection: A dose-finding study","volume":"116","author":"Wittekindt","year":"2006","journal-title":"Laryngoscope"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.otohns.2007.12.021","article-title":"Botulinum toxin for radiation-induced facial pain and trismus","volume":"138","author":"Hartl","year":"2008","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.apmr.2007.11.022","article-title":"The role of botulinum toxin type A in the radiation fibrosis syndrome: A preliminary report","volume":"89","author":"Stubblefield","year":"2008","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1526-4637.2012.01437.x","article-title":"OnabotulinumtoxinA for treatment of focal cancer pain after surgery and\/or radiation","volume":"13","author":"Mittal","year":"2012","journal-title":"Pain Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.anorl.2011.07.002","article-title":"Botulinum toxin in the treatment of post-radiosurgical neck contracture in head and neck cancer: A novel approach","volume":"129","author":"Bach","year":"2012","journal-title":"Eur. Ann. Otorhinolaryngol. Head Neck Dis."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Rostami, R., Mittal, S.O., Radmand, R., and Jabbari, B. (2016). Incobotulinum Toxin-A Improves Post-Surgical and Post-Radiation Pain in Cancer Patients. Toxins, 8.","DOI":"10.3390\/toxins8010022"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.apmr.2017.12.032","article-title":"Effectiveness of Botulinum Toxin A for Persistent Upper Limb Pain After Breast Cancer Treatment: A Double-Blinded Randomized Controlled Trial","volume":"99","author":"Devoogdt","year":"2018","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.canrad.2019.02.001","article-title":"Douleurs post-radiques apr\u00e8s radioth\u00e9rapie pour cancer des voies a\u00e9rodigestives superieures: Traitement par injections de toxine botulique A [Radiation-induced head and neck pain: Management with botulinum toxin a injections]","volume":"23","author":"Mailly","year":"2019","journal-title":"Cancer Radiother."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/mds.870100527","article-title":"Botulinum toxin A is effective in treating trismus associated with postradiation myokymia and muscle spasm","volume":"10","author":"Lou","year":"1995","journal-title":"Mov. Disord."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.1526-4637.2003.03013.x","article-title":"Botulinum toxin a improved pain and allodynia in two patients with intracranial pathology","volume":"4","author":"Jabbari","year":"2003","journal-title":"Pain Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.5535\/arm.2017.41.6.1088","article-title":"Botulinum Toxin Type A Injection for Neuropathic Pain in a Patient With a Brain Tumor: A Case Report","volume":"41","author":"Nam","year":"2017","journal-title":"Ann. Rehabil. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/CND.0000000000000191","article-title":"Radiation-induced painful neurogenic hypertrophy Treated with Botulinum Toxin, A","volume":"19","author":"Filippakis","year":"2018","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/SAP.0000000000001622","article-title":"Botulinum Toxin Injection for Lower Face and Oral Cavity Raynaud Phenomenon after Mandibulectomy, Free Fibula Reconstruction, and Radiation Therapy","volume":"82","author":"Boukovalas","year":"2019","journal-title":"Ann. Plast. Surg."},{"key":"ref_28","first-page":"937","article-title":"Battling Neuropathic Scar Pain with Botulinum Toxin","volume":"18","author":"Schuler","year":"2019","journal-title":"J. Drugs Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10006-012-0375-0","article-title":"Botulinum toxin treatment of salivary fistulas following parotidectomy: Follow-up results","volume":"17","author":"Laskawi","year":"2013","journal-title":"Oral Maxillofac. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.amjoto.2005.09.009","article-title":"The role of botulinum toxin in postparotidectomy fistula treatment. A technical note","volume":"27","author":"Marioni","year":"2006","journal-title":"Am. J. Otolaryngol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10006-004-0575-3","article-title":"Botulinumtoxin zur Behandlung des gustatorischen Schwitzens. Eine prospektive randomisierte Therapiestudie [Botulinum toxin for treatment of gustatory sweating. A prospective randomized study]","volume":"8","author":"Nolte","year":"2004","journal-title":"Mund Kiefer Gesichtschir."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s001150170035","article-title":"Effektivit\u00e4t von Botulinumtoxin A in der Behandlung des gustatorischen Schwitzens [Effectiveness of botulinum toxin A in the treatment of gustatory sweating]","volume":"72","author":"Kuttner","year":"2001","journal-title":"Nervenarzt"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/archotol.126.3.421","article-title":"A pilot study evaluating the treatment of postparotidectomy sialoceles with botulinum toxin type A","volume":"126","author":"Vargas","year":"2000","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"ref_34","first-page":"6627","article-title":"Botulinum toxin for salivary disorders in the treatment of head and neck cancer","volume":"34","author":"Steffen","year":"2014","journal-title":"Anticancer Res."},{"key":"ref_35","first-page":"13","article-title":"Post-surgical role of botulinum toxin-A injection in patients with head and neck cancer: Personal experience","volume":"28","author":"Marchese","year":"2008","journal-title":"Acta Otorhinolaryngol. Ital."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/hed.10262","article-title":"Treatment of gustatory sweating (Frey\u2032s syndrome) with botulinum toxin A","volume":"25","author":"Eckardt","year":"2003","journal-title":"Head Neck"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.otohns.2010.04.009","article-title":"Treatment of Frey\u2032s syndrome with botulinum toxin type B","volume":"143","author":"Cantarella","year":"2010","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"ref_38","first-page":"E248","article-title":"Clinical results in the management of Frey\u2032s syndrome with injections of Botulinum toxin","volume":"13","author":"Nieto","year":"2008","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1017\/S0022215108001771","article-title":"Botulinum toxin A for quality of life improvement in post-parotidectomy gustatory sweating (Frey\u2032s syndrome)","volume":"122","author":"Hartl","year":"2008","journal-title":"J. Laryngol. Otol."},{"key":"ref_40","first-page":"2397","article-title":"Treatment of Frey\u2032s syndrome with botulinum toxin","volume":"90","author":"Pomprasit","year":"2007","journal-title":"J. Med. Assoc. Thail."},{"key":"ref_41","first-page":"187","article-title":"Sindrome di Frey post parotidectomia. Trattamento con tossina botulinica di tipo A [Post-parotidectomy Frey\u2032s syndrome. Treatment with botulinum toxin type A]","volume":"20","author":"Cavalot","year":"2000","journal-title":"Acta Otorhinolaryngol. Ital."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/1097-0142(20001015)89:8<1659::AID-CNCR2>3.0.CO;2-M","article-title":"Frey syndrome: Treatment with type A botulinum toxin","volume":"89","author":"Niederhagen","year":"2000","journal-title":"Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/000348949810700110","article-title":"Botulinum toxin type A for Frey\u2032s syndrome: A preliminary prospective study","volume":"107","author":"Laccourreye","year":"1998","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1017\/S0022215100138769","article-title":"Frey\u2032s syndrome: Treatment with botulinum toxin","volume":"111","author":"Bjerkhoel","year":"1997","journal-title":"J. Laryngol. Otol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1590\/abd1806-4841.20175848","article-title":"Primary treatment of early fistula of parotid duct with botulinum toxin type A injection","volume":"92","author":"Ferron","year":"2017","journal-title":"An. Bras. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.bjoms.2014.06.008","article-title":"Bilateral gustatory sweating in the submandibular region after bilateral neck dissection successfully treated with botulinum toxin","volume":"52","author":"Philouze","year":"2014","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00106-011-2476-8","article-title":"Botulinumtoxin A gegen Hypersalivation. Einsatz bei Wundheilung nach Resektion eines Zungenkarzinoms [Botulinum toxin A after microvascular ALT flap in a patient with (corrected) squamous cell carcinoma of the tongue] [published correction appears in HNO. 2012 Oct; 60, 905]","volume":"60","author":"Ihler","year":"2012","journal-title":"HNO"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1002\/hed.21778","article-title":"Botulinum toxin type b for the treatment of a sialocele after parotidectomy","volume":"35","author":"Pantel","year":"2013","journal-title":"Head Neck"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00106-010-2232-5","article-title":"Drooling nach Strahlentherapie. Botulinumtoxin als erfolgreiches Therapieverfahren [Drooling following radiation. Botulinum toxin as a successful treatment modality]","volume":"59","author":"Steffen","year":"2011","journal-title":"HNO"},{"key":"ref_50","first-page":"1365","article-title":"Parotid fistula complicating surgical excision of a basal cell carcinoma: Successful treatment with botulinum toxin type A","volume":"33","author":"Hill","year":"2007","journal-title":"Dermatol. Surg."},{"key":"ref_51","first-page":"78","article-title":"Parotidektomi sonrasi geli\u015fen t\u00fck\u00fcr\u00fck fist\u00fcl\u00fcn\u00fcn botulinum toksini ile iyile\u015fmesi [Successful use of botulinum toxin injection in the treatment of salivary fistula following parotidectomy]","volume":"10","author":"Kizilay","year":"2003","journal-title":"Kulak Burun Bogaz Ihtis Derg."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1177\/000348940111001214","article-title":"Treatment of postparotidectomy salivary fistula with botulinum toxin","volume":"110","author":"Sittel","year":"2001","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1097\/00005537-199908000-00032","article-title":"Management of parotid sialocele with botulinum toxin","volume":"109","author":"Blotta","year":"1999","journal-title":"Laryngoscope"},{"key":"ref_54","first-page":"478","article-title":"S\u00edndrome de Frey por submaxilectom\u00eda y tratamiento con toxina botul\u00ednica [Frey syndrome secondary to submaxillectomy and botulinic treatment]","volume":"67","author":"Paleari","year":"2007","journal-title":"Medicina (B Aires)"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.joms.2006.10.017","article-title":"Using botox to treat a mohs defect repair complicated by a parotid fistula","volume":"65","author":"Hatzis","year":"2007","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1054\/bjps.1998.3058","article-title":"Botulinum toxoid in the management of gustatory sweating (Frey\u2032s syndrome) after superficial parotidectomy","volume":"52","author":"Birch","year":"1999","journal-title":"Br. J. Plast. Surg."},{"key":"ref_57","first-page":"239","article-title":"Prostatic carcinoma shrunk after intraprostatic injection of botulinum toxin","volume":"8","author":"Vezdrevanis","year":"2011","journal-title":"Urol. J."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Ulloa, F., Gonz\u00e0lez-Junc\u00e0, A., Meffre, D., Barrecheguren, P.J., Mart\u00ednez-M\u00e1rmol, R., Pazos, I., Oliv\u00e9, N., Cotrufo, T., Seoane, J., and Soriano, E. (2015). Blockade of the SNARE protein syntaxin 1 inhibits glioblastoma tumor growth. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0119707"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.humpath.2016.02.001","article-title":"Biologic effect of neurogenesis in pancreatic cancer","volume":"52","author":"He","year":"2016","journal-title":"Hum. Pathol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/pros.20958","article-title":"Botulinum toxin type A inhibits the growth of LNCaP human prostate cancer cells in vitro and in vivo","volume":"69","author":"Karsenty","year":"2009","journal-title":"Prostate"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4014\/jmb.1107.07018","article-title":"Cells transformed by PLC-gamma 1 overexpression are highly sensitive to clostridium difficile toxin A-induced apoptosis and mitotic inhibition","volume":"22","author":"Nam","year":"2012","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5301\/RU.2012.9254","article-title":"Attivit\u00e0 della tossina botulinica A in linee cellulari di cancro prostatico [Botulinum toxin type-A toxin activity on prostate cancer cell lines]","volume":"79","author":"Proietti","year":"2012","journal-title":"Urologia"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"891","DOI":"10.7314\/APJCP.2013.14.2.891","article-title":"Effect of botulinum toxin A on proliferation and apoptosis in the T47D breast cancer cell line","volume":"14","author":"Bandala","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_64","first-page":"8411","article-title":"Botulinum neurotoxin type A inhibits synaptic vesicle 2 expression in breast cancer cell lines","volume":"8","author":"Bandala","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"33220","DOI":"10.18632\/oncotarget.8903","article-title":"Botulinum neurotoxin type C protease induces apoptosis in differentiated human neuroblastoma cells","volume":"7","author":"Rust","year":"2016","journal-title":"Oncotarget"},{"key":"ref_66","first-page":"1060","article-title":"Truncated SNAP-25 (1-197), like botulinum neurotoxin A, can inhibit insulin secretion from HIT-T15 insulinoma cells","volume":"12","author":"Huang","year":"1998","journal-title":"Mol. Endocrinol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.7314\/APJCP.2015.16.14.5977","article-title":"Preparation of Immunotoxin Herceptin-Botulinum and Killing Effects on Two Breast Cancer Cell Lines","volume":"16","author":"Hajighasemlou","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/luts.12003","article-title":"OnobotulinumtoxinA Has No Effects on Growth of LNCaP and PC3 Human Prostate Cancer Cells","volume":"5","author":"Cheng","year":"2013","journal-title":"Low. Urin. Tract Symptoms"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1517\/13543784.16.2.209","article-title":"Use of botulinum toxins in cancer therapy","volume":"16","author":"Ansiaux","year":"2007","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/pros.23454","article-title":"Influence of the neural microenvironment on prostate cancer","volume":"78","author":"Coarfa","year":"2018","journal-title":"Prostate"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Matak, I., B\u00f6lcskei, K., Bach-Rojecky, L., and Helyes, Z. (2019). Mechanisms of Botulinum Toxin Type A Action on Pain. Toxins, 11.","DOI":"10.3390\/toxins11080459"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1055\/s-0036-1571953","article-title":"Botulinum Toxin Treatment of Neuropathic Pain","volume":"36","author":"Mittal","year":"2016","journal-title":"Semin. Neurol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.neuroscience.2009.01.066","article-title":"Botulinum toxin type a (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction","volume":"159","author":"Kitamura","year":"2009","journal-title":"Neuroscience"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.3390\/toxins7082906","article-title":"Cross-Excitation in Peripheral Sensory Ganglia Associated with Pain Transmission","volume":"7","author":"Omoto","year":"2015","journal-title":"Toxins"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.pain.2013.12.009","article-title":"Botulinum toxin B in the sensory afferent: Transmitter release, spinal activation, and pain behavior","volume":"155","author":"Marino","year":"2014","journal-title":"Pain"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.neuroscience.2017.06.004","article-title":"Antinociceptive effect of botulinum toxin A involves alterations in AMPA receptor expression and glutamate release in spinal dorsal horn neurons","volume":"357","author":"Hong","year":"2017","journal-title":"Neuroscience"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.toxicon.2017.05.001","article-title":"Botulinum toxin type A reduces TRPV1 expression in the dorsal root ganglion in rats with adjuvant-arthritis pain","volume":"133","author":"Fan","year":"2017","journal-title":"Toxicon"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"15650","DOI":"10.1523\/JNEUROSCI.2618-11.2011","article-title":"Evidence for anterograde transport and transcytosis of botulinum neurotoxin A (BoNT\/A)","volume":"31","author":"Restani","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuroscience.2011.04.026","article-title":"Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A","volume":"186","author":"Matak","year":"2011","journal-title":"Neuroscience"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2010.01.020","article-title":"Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: Bilateral effect after unilateral injection","volume":"633","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.pbb.2009.08.012","article-title":"Central origin of the antinociceptive action of botulinum toxin type A","volume":"94","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1097\/00002508-200211001-00003","article-title":"Possible mechanisms for the effects of botulinum toxin on pain","volume":"18","author":"Arezzo","year":"2002","journal-title":"Clin. J. Pain."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2217\/fon-2016-0423","article-title":"Cancer pain: A review of epidemiology, clinical quality and value impact","volume":"13","author":"Neufeld","year":"2017","journal-title":"Future Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2217\/pmt.14.33","article-title":"Predicting, preventing and managing persistent pain after breast cancer surgery: The importance of psychosocial factors","volume":"4","author":"Schreiber","year":"2014","journal-title":"Pain Manag."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0360-3016(00)00782-3","article-title":"Randomized phase III study comparing best supportive care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group [RTOG] 97\u201313","volume":"48","author":"Fisher","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.canrad.2009.04.003","article-title":"Importance of local skin treatments during radiotherapy for prevention and treatment of radio-induced epithelitis","volume":"13","author":"Chargari","year":"2009","journal-title":"Cancer Radiother."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.radonc.2011.05.014","article-title":"Can we decrease the skin reaction in breast cancer patients using hyaluronic acid during radiation therapy-results of phase III randomised trial","volume":"100","author":"Kirova","year":"2011","journal-title":"Radiother. Oncol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1155\/2009\/723179","article-title":"Use of lidocaine patches for neuropathic pain in a comprehensive cancer center","volume":"14","author":"Fleming","year":"2009","journal-title":"Pain Res. Manag."},{"key":"ref_89","first-page":"CD011056","article-title":"Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain","volume":"5","author":"Wiffen","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3390\/toxins5051010","article-title":"Sialorrhea, anatomy, physiology and treatment with emphasis on the role of botulinum toxins","volume":"5","author":"Lakraje","year":"2013","journal-title":"Toxins"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1017\/S0022215100069607","article-title":"Combined surgical-radiological treatment of parotid gland fistulae","volume":"82","author":"Schindel","year":"1968","journal-title":"J. Laryngol. Otol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"168","DOI":"10.14639\/0392-100X-1608","article-title":"Botulinum toxin therapy: Functional silencing of salivary disorders. Terapia con tossina botulinica: Silenziamento funzionale dei disordini salivari","volume":"37","author":"Lovato","year":"2017","journal-title":"Acta Otorhinolaryngol. Ital."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/12\/1\/32\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:28:50Z","timestamp":1760362130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/12\/1\/32"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,5]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1]]}},"alternative-id":["toxins12010032"],"URL":"https:\/\/doi.org\/10.3390\/toxins12010032","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,5]]}}}